Multiplex CLIA-waived point-of-care tests for SARS-CoV-2, influenza A and B, ± other respiratory pathogens: A systematic review.

Background: Many multiplex CLIA-waived point of care tests are available in the United States for community pharmacists to incorporate into their practice.

Objective: To characterize the eleven multiplex CLIA-waived point of care tests available for detecting SARS-CoV-2 and influenza A and B ± other respiratory pathogens and summarize their performance characteristics from published studies.

Methods: Food and Drug Administration websites and databases were utilized to identify currently available tests.

Molecular point-of-care testing in the community pharmacy setting: current status and future prospects.

Introduction: Clinical Laboratory Improvement Amendments (CLIA)-waived point-of-care tests (POCTs) have been available since the late 1980s, but their use in community pharmacy has expanded over the last several years. Barriers exist for community-pharmacy-based CLIA-waived POC testing, including pharmacy workflow, pharmacist scope of practice, and reimbursement. As pharmacies work to reduce these barriers, the number of pharmacies participating in POCT programs has dramatically increased.

Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps.

To review published literature for biologic treatment of nasal polyps. PubMed search performed on February 16, 2022, using search terms: biologics, benralizumab, dupilumab, mepolizumab, omalizumab, or reslizumab AND nasal polyps, nasal polyposis, or chronic rhinosinusitis with nasal polyposis (CRSwNP). Inclusion criteria were English language, published randomized controlled trials, post hoc analyses, and meta-analyses evaluating biologics for nasal polyposis, with or without comorbid asthma, and no date limits.

A systematic review comparing at-home diagnostic tests for SARS-CoV-2: Key points for pharmacy practice, including regulatory information.

Background: Home-based rapid diagnostic testing can play an integral role in controlling the spread of coronavirus disease 2019 (COVID-19).

Objectives: This review aimed to identify and compare at-home diagnostic tests that have been granted Emergency Use Authorizations (EUAs) and convey details about COVID-19 diagnostic tests, including regulatory information, pertinent to pharmacy practice.

Methods: The Food and Drug Administration (FDA) online resources pertaining to COVID-19 tests, EUAs, and medical devices were consulted, as were linked resources from FDA's webpages.

Comparison of Monoclonal Antibodies for Treatment of Uncontrolled Eosinophilic Asthma.

Objective: To summarize the current literature for Food and Drug Administration (FDA)-approved monoclonal antibodies used as add-on maintenance therapy in uncontrolled eosinophilic asthma.

Data Sources: PubMed was searched on December 17, 2018 using keywords: .

Study Selection: Studies evaluating safety and efficacy of monoclonal antibodies for treatment of severe or eosinophilic asthma were included.

Efficacy and Safety of Alpha-Blockers for Kidney Stones in Adults.

To review the literature for α-blocker treatment of kidney stones. PubMed search performed November 15, 2017, using the following search terms: alpha-blocker, alfuzosin, silodosin, or tamsulosin AND kidney or ureteral stones. Additional studies found through references of primary and tertiary literature.

A systematic review of rapid diagnostic tests for influenza: considerations for the community pharmacist.

Objectives: Rapid influenza diagnostic tests (RIDTs) have a potential role in community pharmacy to optimize influenza infection management. The U.S.

Identifying and locating pharmacist certificate programs, traineeships, and certification agencies.

Objective: To provide a list of available certification and certificate programs that can be completed to enhance or validate pharmacists' knowledge and skills in the treatment of specific diseases.

Data Sources: Medline/PubMed searched using the terms "pharmacist" and "certification" or "pharmacist" and "credentialing"; Web sites of national pharmacy organizations.

Data Synthesis: No information was found in Medline/PubMed about the value of certification or certificate programs for pharmacists.

Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus.

This article gives a practical review of the pharmacology, clinical efficacy, safety, dosing, cost, and place in therapy for oral antihyperglycemic agents used in the treatment of type 2 diabetes mellitus. There are 5 classes of oral antihyperglycemic agents available in the United States: sulfonylurea secretagogues, biguanides, alpha-glucosidase inhibitors, thiazolidinediones, and nonsulfonylurea secretagogues. These agents have distinct characteristics that help in their selection for the treatment of type 2 diabetes.